Anti-(homo Sapiens Rhd(rhesus Blood Group D Antigen Uses, Dosage, Side Effects and more
Anti-(homo Sapiens Rhd(rhesus Blood Group D Antigen is under investigation in clinical trial NCT02287896 (Pharmacokinetics and Safety of Anti-(homo Sapiens Rhd(rhesus Blood Group D Antigen in Rhd-negative Pregnant Women Carrying an Rhd-positive Foetus).
| Attribute | Details |
|---|---|
| Trade Name | Anti-(homo Sapiens Rhd(rhesus Blood Group D Antigen |
| Generic | Roledumab |
| Roledumab Other Names | Immunoglobulin g1-kappa, anti-(homo sapiens rhd(rhesus blood group d antigen, rhd, cd240d)), homo sapiens monoclonal antibody, Roledumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
